Cardiovascular Disorders as a Result of COVID-19

Liudmila Kovalevskaiia; Alireza Pakhlevanzade; Svetlana  Ivanchenko; Larysa Kupriianova; Veronika Volianska; Alexander Plakida; Pradosh Panigrahi

doi:10.3889/oamjms.2022.9593

Authors

Liudmila Kovalevskaiia The International Humanitarian University, Odessa, Ukraine
Alireza Pakhlevanzade The International Humanitarian University, Odessa, Ukraine
Svetlana Ivanchenko The International Humanitarian University, Odessa, Ukraine
Larysa Kupriianova The International Humanitarian University, Odessa, Ukraine
Veronika Volianska Odessa National Medical University, Odessa, Ukraine
Alexander Plakida Odessa National Medical University, Odessa, Ukraine https://orcid.org/0000-0002-7537-7596
Pradosh Panigrahi Odessa National Medical University, Odessa, Ukraine

DOI:

https://doi.org/10.3889/oamjms.2022.9593

Keywords:

COVID-19, Cardiovascular complications, Myocardial damage

Abstract

Based on the literature data, we present current literature information about frequency, main spectrum, and prognostic value of cardiovascular complications of the SARS-CoV-2 infection. We have highlighted in detail the variants of cardiovascular disorders in the case of patients with SARS-CoV-2 infection caused by concomitant diseases of hypertension, acute coronary syndrome, myocardial infarction, arrhythmias, virus-associated myocarditis, and heart failure. We have described the adverse cardiovascular effects of medicines of different groups used to treat COVID-19 disease and possible medical interactions. We have summarized some current recommendations on cardiotonic and cardioprotective therapy in the case of patients with cardiovascular complications.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Chen C, Zhou Y, Wang DW. SARS-CoV-2: A potential novel etiology of fulminant myocarditis. Herz. 2020;45:230-2. http://doi.org/10.1007/s00059-020-04909-z PMid:32140732 DOI: https://doi.org/10.1007/s00059-020-04909-z

Yu CM, Wong RS, Wu EB, Kong SL, Wong J, Yip GW, et al. Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J. 2006;82(964):140-4. http://doi.org/10.1136/pgmj.2005.037515 PMid:16461478 DOI: https://doi.org/10.1136/pgmj.2005.037515

Alhogbani T. Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann Saudi Med. 2016;36(1):78-80. http://doi.org/10.5144/0256-4947.2016.78 PMid:26922692 DOI: https://doi.org/10.5144/0256-4947.2016.78

Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):819-24. http://doi.org/10.1001/jamacardio.2020.1096 PMid:32219357 DOI: https://doi.org/10.1001/jamacardio.2020.1096

Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531-8. http://doi.org/10.1007/s00392-020-01626-9 PMid:32161990 DOI: https://doi.org/10.1007/s00392-020-01626-9

Zhu H, Rhee JW, Cheng P, Waliany S, Chang A, Witteles RM, et al. Cardiovascular complications in patients with COVID-19: Consequences of viral toxicities and host immune response. Curr Cardiol Rep. 2020;22(5):32. http://doi.org/10.1007/s11886-020-01292-3 PMid:32318865 DOI: https://doi.org/10.1007/s11886-020-01292-3

Williams B, Zhang Y. Hypertension, renin-angiotensinaldosterone system inhibition, and COVID-19. Lancet. 2020;395(10238):1671-3. http://doi.org/10.1016/S0140-6736(20)31131-4 PMid:32416786 DOI: https://doi.org/10.1016/S0140-6736(20)31131-4

Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensinconverting enzyme 2. Circulation. 2005;111(20):2605-10. http://doi.org/10.1161/CIRCULATIONAHA.104.510461 PMid:15897343 DOI: https://doi.org/10.1161/CIRCULATIONAHA.104.510461

Burchill LJ, Velkoska E, Dean RG, Griggs K, Patel SK, Burrell LM. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: Implications for future therapeutic directions. Clin Sci (Lond). 2012;123(11):649-58. http://doi.org/10.1042/CS20120162 PMid:22715807 DOI: https://doi.org/10.1042/CS20120162

Official Website of the American College of Cardiology. Available from: https://www.acc.org/latest-in-cardiology/articles/2020/03/17/08/59/hfsa-acc-aha-statement-addresses-concerns-re-using-raas-antagonists-in-covid-19.

Official Website of the European Society of Cardiology. Available from: https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitorsand-ang. [Last accessed on 2021 Oct 20].

Official Website of the Russian Society of Cardiology. Available from: https://scardio.ru/news/novosti_obschestva/lechenie_iapf_ili_bra_vo_vremya_pandemii_covid19/. [Last accessed on 2021 Oct 20].

de Abajo FJ, Rodríguez-Martín S, Lerma V, Mejía-Abril G, Aguilar M, García-Luque A, et al. Use of reninangiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: A case-population study. Lancet. 2020;395(10238):1705-14. http://doi.org/10.1016/S0140-6736(20)31030-8 PMid:32416785 DOI: https://doi.org/10.1016/S0140-6736(20)31030-8

Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802-10. http://doi.org/10.1001/jamacardio.2020.0950 PMid:32211816 DOI: https://doi.org/10.1001/jamacardio.2020.0950

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395(10229):1054-62. http://doi.org/10.1016/S0140-6736(20)30566-3 PMid:32171076 DOI: https://doi.org/10.1016/S0140-6736(20)30566-3

Aghagoli G, Gallo Marin B, Soliman LB, Sellke FW. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review. J Card Surg. 2020;35(6):1302-5. http://doi.org/10.1111/jocs.14538 PMid:32306491 DOI: https://doi.org/10.1111/jocs.14538

Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020;31(5):1003-8. http://doi.org/10.1111/jce.14479 PMid:32270559 DOI: https://doi.org/10.1111/jce.14479

Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020;38(7):1504-7. http://doi.org/10.1016/j.ajem.2020.04.048 PMid:32317203 DOI: https://doi.org/10.1016/j.ajem.2020.04.048

Yang C, Jin Z. An acute respiratory infection runs into the most common noncommunicable epidemic-COVID-19 and cardiovascular diseases. JAMA Cardiol. 2020;5(7):743-4. http://doi.org/10.1001/jamacardio.2020.0934 PMid:32211809 DOI: https://doi.org/10.1001/jamacardio.2020.0934

Budrys P, Lizaitis M, Cerlinskaite-Bajore K, Bajoras V, Rodevic G, Martinonyte A, et al. Increase of myocardial ischemia time and short-term prognosis of patients with acute myocardial infarction during the first COVID-19 pandemic wave. Medicina (Kaunas). 2021;57(12):1296. http://doi.org/10.3390/medicina57121296 PMid:34946241 DOI: https://doi.org/10.3390/medicina57121296

Coromilas EJ, Kochav S, Goldenthal I, Biviano A, Garan H, Goldbarg S, et al. Worldwide survey of COVID-19-associated arrhythmias. Circ Arrhythm Electrophysiol. 2021;14(3):e009458. http://doi.org/10.1161/CIRCEP.120.009458 PMid:33554620 DOI: https://doi.org/10.1161/CIRCEP.120.009458

Fatmi SS, Basso R, Liaqat A, Tariq F, Swamiappan R. COVID-19 myocarditis: Rationale for early diagnosis and intervention. Cureus. 2021;13(7):e16494. http://doi.org/10.7759/cureus.16494 PMid:34430109 DOI: https://doi.org/10.7759/cureus.16494

Gatto MC, Persi A, Tung M, Masi R, Canitano S, Kol A. Bradyarrhythmias in patients with SARS-CoV-2 infection: A narrative review and a clinical report. Pacing Clin Electrophysiol. 2021;44(9):1607-15. http://doi.org/10.1111/pace.14308 PMid:34219243 DOI: https://doi.org/10.1111/pace.14308

Giustino G, Croft LB, Stefanini GG, Bragato R, Silbiger JJ, Vicenzi M, et al. Characterization of myocardial injury in patients with COVID-19. J Am Coll Cardiol. 2020;76(18):2043-55. http://doi.org/10.1016/j.jacc.2020.08.069 PMid:33121710 DOI: https://doi.org/10.1016/j.jacc.2020.08.069

Italia L, Tomasoni D, Bisegna S, Pancaldi E, Stretti L, Adamo M, et al. COVID-19 and heart failure: From epidemiology during the pandemic to myocardial injury, myocarditis, and heart failure sequelae. Front Cardiovasc Med. 2021;8:713560. http://doi.org/10.3389/fcvm.2021.713560 PMid:34447795 DOI: https://doi.org/10.3389/fcvm.2021.713560

Kini A, Cao D, Nardin M, Sartori S, Zhang Z, Pivato CA, et al. Types of myocardial injury and mid-term outcomes in patients with COVID-19. Eur Heart J Qual Care Clin Outcomes. 2021;7(5):438-46. http://doi.org/10.1093/ehjqcco/qcab053 PMid:34458912 DOI: https://doi.org/10.1093/ehjqcco/qcab053

Mele D, Flamigni F, Rapezzi C, Ferrari R. Myocarditis in COVID-19 patients: Current problems. Intern Emerg Med. 2021;16:1123-9. http://doi.org/10.1007/s11739-021-02635-w PMid:33484452 DOI: https://doi.org/10.1007/s11739-021-02635-w

Sharma N, Joshi P, Gupta PK, Shukla PK, Archna. Effects of Covid-19 on patients with cardiovascular diseases: A systematic review. J Pharm Res Int. 2021;33(53B):130-5. http://doi.org/10.9734/jpri/2021/v33i53B33689 DOI: https://doi.org/10.9734/jpri/2021/v33i53B33689

Tondas AE, Mulawarman R, Trifitriana M, Nurmaini S, Irfannuddin I. Arrhythmia risk profile and ventricular repolarization indices in COVID-19 patients: A systematic review and meta-analysis. J Infect Dev Ctries. 2021;15(2):224-9. http://doi.org/10.3855/jidc.13922 PMid:33690204 DOI: https://doi.org/10.3855/jidc.13922

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. http://doi.org/10.1016/S0140-6736(20)30183-5 PMid:31986264 DOI: https://doi.org/10.1016/S0140-6736(20)30183-5

Ruan Q, Yang K, Wang W, Jiang L, Song J. Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(6):1294-7. http://doi.org/10.1007/s00134-020-06028-z PMid:32253449 DOI: https://doi.org/10.1007/s00134-020-06028-z

Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811-8. http://doi.org/10.1001/jamacardio.2020.1017 PMid:32219356 DOI: https://doi.org/10.1001/jamacardio.2020.1017

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420-2. http://doi.org/10.1016/S2213-2600(20)30076-X PMid:32085846 DOI: https://doi.org/10.1016/S2213-2600(20)30076-X

Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009;39(7):618-25. http://doi.org/10.1111/j.1365-2362.2009.02153.x PMid:19453650 DOI: https://doi.org/10.1111/j.1365-2362.2009.02153.x

Lomivorotov VV, Lomivorotov VN. Perioperative injury and myocardial infarction. Bull Anesthesiol Resusc. 2019;16(2):51-6. https://doi.org/10.21292/2078-5658-2019-16-2-51-56 DOI: https://doi.org/10.21292/2078-5658-2019-16-2-51-56

Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, et al. Acute myocardial infarction after laboratoryconfirmed influenza infection. N Engl J Med. 2018;378(4):345-53. http://doi.org/10.1056/NEJMoa1702090 PMid:29365305 DOI: https://doi.org/10.1056/NEJMoa1702090

Welt FG, Shah PB, Aronow HD, Bortnick AE, Henry TD, Sherwood MW, et al. Catheterization Laboratory Considerations during the Coronavirus (COVID-19) Pandemic: From the ACC’s Interventional Council and SCAI. J Am Coll Cardiol. 2020;75(18):2372-5. https://doi.org/10.1016/j.jacc.2020.03.021 PMid:32199938 DOI: https://doi.org/10.1016/j.jacc.2020.03.021

Zeng J, Huang J, Pan L. How to balance acute myocardial infarction and COVID-19: The protocols from Sichuan Provincial People’s Hospital. Intensive Care Med. 2020;46(6):1111-3. http://doi.org/10.1007/s00134-020-05993-9 PMid:32162032 DOI: https://doi.org/10.1007/s00134-020-05993-9

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. http://doi.org/10.1001/jama.2020.1585 PMid:32031570 DOI: https://doi.org/10.1001/jama.2020.1585

Mehra MR, Desai SS, Ruschitzka F, Patel AN. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: A multinational registry analysis. Lancet. 2020:S0140-6. http://doi.org/10.1016/S0140-6736(20)31180-6 PMid:32450107 DOI: https://doi.org/10.1016/S0140-6736(20)31180-6

Kozlov IA, Tyurin IN. Septic cardiopathy: Controversial issues and prospects. Bull Anesthesiol Resusc. 2020;17(2):49-58. http://doi.org/10.21292/2078-5658-2020-17-2-49-58 DOI: https://doi.org/10.21292/2078-5658-2020-17-2-49-58

Anesthesiological and Resuscitation Support for Patients with a New Coronavirus Infection COVID-19: Guidelines. Official Website of the Federation of Anesthesiologists and Resuscitators. Available from: http://www. far.org.ru/recomendation. [Last accessed on 2021 Oct 20].

Eremenko AA. Drug treatment of acute heart failure: What is and what awaits us. Bull Anesthesiol Resusc. 2020;17(2):29-37. https://doi.org/10.21292/2078-5658-2020-17-2-29-37 DOI: https://doi.org/10.21292/2078-5658-2020-17-2-29-37

Avdeikin SN, Tyurin IN, Kozlov IA. Correction of hemodynamics in severe community-acquired pneumonia complicated by acute respiratory distress syndrome. Med Alphabet. 2018;2(18):19-28.

Gurwitz D. Angiotensin receptor blockers as tentative SARSCoV-2 therapeutics. Drug Dev Res. 2020;81(5):537-40. http://doi.org/10.1002/ddr.21656 PMid:32129518 DOI: https://doi.org/10.1002/ddr.21656

Bautin AE, Osovskikh VV. Acute right ventricular failure. Bull Anesthesiol Resusc. 2018;15(5):74-86. https://doi.org/10.21292/2078-5658-2018-15-5-74-86 DOI: https://doi.org/10.21292/2078-5658-2018-15-5-74-86

Gaddi AV, Galuppo P, Yang J. Creatine phosphate administration in cell energy impairment conditions: A summary of past and present research. Heart Lung Circ. 2017;26(10):1026-35. http://doi.org/10.1016/j.hlc.2016.12.020 PMid:28392102 DOI: https://doi.org/10.1016/j.hlc.2016.12.020

Niu L, An XJ, Tian J, Wang Y. 124 cases of clinical analysis of children with viral myocarditis. Eur Rev Med Pharmacol Sci 2015;19(15):2856-9.

Belova YN, Tarasova AA, Ostreikov IF. The effectiveness of cardiotrophic therapy in newborns with posthypoxic myocardial damage. Gen Resusc. 2011;7(4):38-42. https://doi.org/10.15360/1813-9779-2011-4-38 DOI: https://doi.org/10.15360/1813-9779-2011-4-38